Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response
Deep brain stimulation (DBS) has been proposed as an alternative to ablative neurosurgery for severe treatment-resistant Obsessive-Compulsive Disorder (OCD), although with partially discrepant results probably related to differences in anatomical targetting and stimulation conditions. We sought to d...
Saved in:
Published in | PloS one Vol. 10; no. 7; p. e0133591 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
24.07.2015
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Deep brain stimulation (DBS) has been proposed as an alternative to ablative neurosurgery for severe treatment-resistant Obsessive-Compulsive Disorder (OCD), although with partially discrepant results probably related to differences in anatomical targetting and stimulation conditions. We sought to determine the efficacy and tolerability of DBS in OCD and the existence of clinical predictors of response using meta-analysis.
We searched the literature on DBS for OCD from 1999 through January 2014 using PubMed/MEDLINE and PsycINFO. We performed fixed and random-effect meta-analysis with score changes (pre-post DBS) on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) as the primary-outcome measure, and the number of responders to treatment, quality of life and acceptability as secondary measures.
Thirty-one studies involving 116 subjects were identified. Eighty-three subjects were implanted in striatal areas--anterior limb of the internal capsule, ventral capsule and ventral striatum, nucleus accumbens and ventral caudate--27 in the subthalamic nucleus and six in the inferior thalamic peduncle. Global percentage of Y-BOCS reduction was estimated at 45.1% and global percentage of responders at 60.0%. Better response was associated with older age at OCD onset and presence of sexual/religious obsessions and compulsions. No significant differences were detected in efficacy between targets. Five patients dropped out, but adverse effects were generally reported as mild, transient and reversible.
Our analysis confirms that DBS constitutes a valid alternative to lesional surgery for severe, therapy-refractory OCD patients. Well-controlled, randomized studies with larger samples are needed to establish the optimal targeting and stimulation conditions and to extend the analysis of clinical predictors of outcome. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Conceived and designed the experiments: PA DC LG BDG LM JMM. Analyzed the data: PA DC LG LM ST JMM. Contributed reagents/materials/analysis tools: DD WG FJ JK DL BN ER CS RS. Wrote the paper: PA LG DD BDG JK LM BN JMM. Competing Interests: Pino Alonso, Cinto Segalas, Eva Real and José M. Menchón participate in a postmarket clinical follow-up study sponsored by Medtronic (Reclaim Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder: Post-Market Clinical Followup Study [OCD PMCF], registered on www.ClinicalTrials.gov, NCT01135745. José M.Menchón received grants for education and travel from Eli Lilly, Janssen, Lundbeck,Otsuka, Rovi and Servier. Loes Gabriëls is holder of the Chair for neurosurgery in psychiatric disorders at the KU Leuven, funded by Medtronic. Damiaan Denys and Rick Schuurman received unrestricted grants form Medtronic. Jens Kuhn and Doris Lenartz received financial support for IIT-DBS studies from Medtronic AG (Meerbusch, Germany). Luc Mallet received travel grants from Medtronic and consulting fees from AstraZeneca. Bart Nuttin received grants for research, education and travel from Cover Letter Medtronic. He owns a patent on DBS for OCD. He has a chair, 'stereotactic neurosurgery for psychiatric disorders', a donation from Medtronic. Daniel Cuadras, Wayne Goodman, Ben D. Greenberg, Fiacro Jiménez-Ponce and Sophie Tezenas du Montcel have declared that no competing interest exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0133591 |